Clonidine Guidelines for Hypertension and ADHD

Introduction to Clonidine Management

The European Society of Cardiology recommends ACE inhibitors, ARBs, dihydropyridine calcium channel blockers, and thiazides/thiazide-like drugs as first-line treatments for hypertension, with clonidine reserved as a last-line agent 1
Clonidine is not a first-line agent for hypertension and should only be considered after failure of other treatments, according to the European Heart Journal 1, 2, 3

The American College of Cardiology recommends clonidine as a last-line agent, added only after other combination therapies have failed to achieve blood pressure control, with a strength of evidence rated as moderate 3
For hypertensive urgencies, immediate-release nifedipine is preferred over clonidine due to faster onset of action, but clonidine can be used when nifedipine is unavailable or contraindicated, with a target reduction of at least 20/10 mmHg 2, 4
The starting dose of clonidine for chronic hypertension is 0.05-0.1 mg orally at bedtime, with a maximum dose of 0.4 mg per day, according to the American Journal of Obstetrics and Gynecology 5

The American Academy of Pediatrics recommends stimulants as first-line therapy for ADHD, with clonidine as a second-line treatment, due to its smaller effect size and slower onset of action 6
The starting dose of clonidine for ADHD is 0.1 mg tablet at bedtime, with a maximum dose of 0.4 mg/day, and transdermal patches available in 0.1, 0.2, and 0.3 mg dosages 6

Clonidine could be considered as an adjunct agent for ADHD in pregnancy following risk-benefit discussion, acknowledging limited safety and efficacy data, according to the American Journal of Obstetrics and Gynecology 5
Caution is advised when using clonidine during breastfeeding, as it is present in human milk and detectable in infant serum, with a recommended monitoring of infants for drowsiness, hypotonia, vomiting, diarrhea, jitteriness, sedation, and seizures 5

Do not use clonidine as first-line therapy for either hypertension or ADHD, as it is consistently positioned as second-line or later in treatment algorithms, with a strength of evidence rated as high 1, 6, 3
Do not treat asymptomatic elevated blood pressure too aggressively in outpatient settings, as observational studies suggest intensive treatment may worsen outcomes, including acute kidney injury and stroke, with a strength of evidence rated as moderate 2